Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells

Journal of Nuclear Medicine

Volumn 39, Issue 7, 1998, Pages 1214-1218

  Moretti, Jean Luc ^a   Cordobes, Muriel Duran ^b   Starzec, Anna ^b   De Beco, Virginie ^b   Vergote, Jackie ^b   Benazzouz, Fatima ^b   Boissier, Brigitte ^b   Cohen, Hélène ^b   Safi, Nour ^b   Piperno Neumann, Sophie ^b   Kouyoumdjian, Jean Claude ^b  

^a AVICENNE HOSPITAL   (France)

^b NONE

Author keywords

Buthionine sulfoximine; Glutathione; Human cancer cell lines; Multidrug resistance; Technetium 99m hexakis 2 methoxyisobutyl isonitrile

Indexed keywords

BUTHIONINE SULFOXIMINE; GLUTATHIONE; MEMBRANE PROTEIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CELL MEMBRANE TRANSPORT; DRUG UPTAKE; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; ISOTOPE LABELING; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; GENES, MDR; GLUTATHIONE; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TUMOR CELLS, CULTURED;

EID: 17144462114     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Van Kalken CK, Pinedo HM, Giaccone G. Multidrug resistance from the clinical point of view. Eur J Cancer 1991;27:1481-1486.
2. Simon SM, Schindler M. Cell biological mechanisms of multidrug resistance in tumors. Prof Natl Acad Sci USA 1994;91:3497-3504.
3. Pastan I, Gottesman M. Multiple-drug resistance in human cancer. N Engl J Med 1987;316:1388-1393.
4. Gottesman M, Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem 1988;263:12163-12166.
5. Cole S, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC) 1992;258: 1650-1654.
6. Zaman GJR, Flens MJ, Van Leusden MR, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 1994;91:8822-8826.
7. Mannervick B, Danielson UH. Glutathione transferase-structure and catalytic activity. Crit Rev Biochem 1988;23:283-288.
8. Beck WT. Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance. J Natl Cancer Inst 1989;81:1683-1685.
9. Bellamy C, Harrisson DJ. Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast. Br J Cancer 1994;69:183-185.
10. Arias IM, Jakoby WB. Glutathione: metabolism and function. New York: Raven Press; 1976;6,1:382-392.
11. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 1996;56:988-994.
12. Abrams MJ, Davison A, Jones AG, Costello C. Synthesis and characterization of hexakis (alkyl isocyanide) and hexakis (aryl isocyanide) complexes of technetium (I). Inorg Chem 1983;22:2798-2800.
13. Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methosyisobutyllsonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardical perfusion imaging. J Nucl Med 1989;30:301-311.
14. Piwnica-Worms D, Rao VV, Kronauge JF, Croop M. Characterization of multidrug resistance p-glycoprotein transport function with an organotechnetium cation. Biochem 1995;34:12210-12220.
15. Duran Cordobes M, Starzec A, Delmon-Moingeon L, et al. Technetium-99m sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 1996;37:286-289.
16. Delmon-Moingeon L, Piwnica-Worms D, Van den Abbele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis (2-methoxyisobutylisonitrile)-technelium-99m by human carcinoma cells lines in vitro. Cancer Res 1990;50:2198-2202.
17. Maublant JC, Zhang Z, Rapp M, Michelot J, Veyre A. In vitro uptake of technetium-99m-tereboxime in carcinoma cell lines and normal cells:comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 1993;34:1949-1952.
18. Moretti JL, Duran Cordobes M, de Beco V, et al. Technetium-99m sestamibi uptake in human cancer cell lines resistant to chemotherapy mediated by multidrug resistance associated protein (MRP)[Abstract]. J Nucl Med 1996;37:233P.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
20. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and non protein sulfhydryl-groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192-205.
21. Vickers PJ, Dickson RB, Shoemaker R, Cowan KH. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone independent tumor growth. Mol Endocrinol 1988;2:886-892.
22. Akiyama S, Fojo A, Hanover JA, Pastan I, Gottesman MM. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet 1985;11:117-126.
23. Lieber M, Smith B, Szakal A, Nelson-Roes W, Todaro G. A continuous tumor cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976;17:62-70.
24. Slovak ML, Ho JP, Bhardwja G, Kurz EV, Deeley RG, Cole S. Localization of a novel multidrug resistance associated gene in the HT 1080/DR4 and H69 AR human tumor cell lines. Cancer Res 1993;53:3221-3285.
25. Kabasakal L, Özker K, Hayward M, et al. Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance. Eur J Nucl Med 1996;23:568-570.
26. Crankshaw C, Piwnica-Worms D. Technetium-99m-sestamibi may be a transport substrate of the human multidrug resistance-associated protein (MRP) [Abstract]. J Nucl Med 1996;37:247P.
27. 99mTc-scstamibi accumulation in Pgp positive and MRP positive cell lines [Abstract]. Proc Am Assoc Cancer Rex 1995;36:358.
28. Hendrikse NH, de Vries EGE, van der Graaf WTA, et al. Technetium-99m-sestamibi is transported by P-glycoprotein and the multidrug associated protein[ Abstract]. J Nucl Med 1996;37:353P.
29. Kenneth DT. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994;54:4313-4320.
30. Moldeus P, Quanguan J. Importance of glutathione cycle in drug metabolism. Pharmacol Ther 1987;33:37-40.
31. Salnikov K, Gao M, Voitkun V, Huang X, Costa M. Altered oxidative stress responses in nickel-resistant mammalian cells. Cancer Res 1994;54:6407-6412.
32. Lewis AD, Hickson ID, Robson CN, et al. Amplification and increased expression of alpha class glutathione S-transferase encoding genes associated with resistance to nitrogen mustards. Proc Natl Acad Sci USA 1988;85:8511-8517.
33. Shen H, Saptarshi P, Breuninger LM, et al. Cellular and in vitro transport of glutathione conjugates by MRP. Biochemistry 1996;35:5719-5725.
34. Jocelyn P. Some properties of mitochondrial glutathione. Biochem Biophys Acta 1975;396:427-436.
35. Jedlitschky G, Leier I, Buchholz V, Center M, Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 1994;54:4833-4836.
36. 4 and structurally related conjugates. J Biol Chem 1994;269:27807-27810.
37. Feller N, Broxtermann HJ, Währer DCR, Pinedo HM. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett 1995;368:385-388.